199 related articles for article (PubMed ID: 35171114)
1. Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramine.
Richter S; Qiu B; Ghering M; Kunath C; Constantinescu G; Luths C; Pamporaki C; Bechmann N; Meuter L; Kwapiszewska A; Deutschbein T; Nölting S; Peitzsch M; Robledo M; Prejbisz A; Pacak K; Gudziol V; Timmers HJLM; Eisenhofer G
Endocr Relat Cancer; 2022 Mar; 29(4):213-224. PubMed ID: 35171114
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Malignant Head and Neck Paragangliomas at a Single Institution Across Multiple Decades.
McCrary HC; Babajanian E; Calquin M; Carpenter P; Casazza G; Naumer A; Greenberg S; Kohlmann W; Cannon R; Monroe MM; Hunt JP; Buchmann L
JAMA Otolaryngol Head Neck Surg; 2019 Jul; 145(7):641-646. PubMed ID: 31194233
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas.
Bernardo-Castiñeira C; Sáenz-de-Santa-María I; Valdés N; Astudillo A; Balbín M; Pitiot AS; Jiménez-Fonseca P; Scola B; Tena I; Molina-Garrido MJ; Sevilla MA; Beristein E; Forga L; Villabona C; Oriola J; Halperin I; Suarez C; Chiara MD
Head Neck; 2019 Jan; 41(1):79-91. PubMed ID: 30549360
[TBL] [Abstract][Full Text] [Related]
4. Identification of a signaling axis HIF-1α/microRNA-210/ISCU independent of SDH mutation that defines a subgroup of head and neck paragangliomas.
Merlo A; de Quiros SB; Secades P; Zambrano I; Balbín M; Astudillo A; Scola B; Arístegui M; Suarez C; Chiara MD
J Clin Endocrinol Metab; 2012 Nov; 97(11):E2194-200. PubMed ID: 22977270
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT as a predictor of hereditary head and neck paragangliomas.
Blanchet EM; Gabriel S; Martucci V; Fakhry N; Chen CC; Deveze A; Millo C; Barlier A; Pertuit M; Loundou A; Pacak K; Taïeb D
Eur J Clin Invest; 2014; 44(3):325-332. PubMed ID: 24422786
[TBL] [Abstract][Full Text] [Related]
6. Catecholamine-Synthesizing Enzymes Are Expressed in Parasympathetic Head and Neck Paraganglioma Tissue.
Osinga TE; Korpershoek E; de Krijger RR; Kerstens MN; Dullaart RP; Kema IP; van der Laan BF; van der Horst-Schrivers AN; Links TP
Neuroendocrinology; 2015; 101(4):289-95. PubMed ID: 25677368
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic patterns in patients with the head-and-neck paragangliomas associate with differential clinical characteristics.
Chen H; Zhu W; Li X; Xue L; Wang Z; Wu H
J Cancer Res Clin Oncol; 2017 Jun; 143(6):953-960. PubMed ID: 28255624
[TBL] [Abstract][Full Text] [Related]
8. Phaeochromocytoma: a catecholamine and oxidative stress disorder.
Pacak K
Endocr Regul; 2011 Apr; 45(2):65-90. PubMed ID: 21615192
[TBL] [Abstract][Full Text] [Related]
9. Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.
Rao D; Peitzsch M; Prejbisz A; Hanus K; Fassnacht M; Beuschlein F; Brugger C; Fliedner S; Langton K; Pamporaki C; Gudziol V; Stell A; Januszewicz A; Timmers HJLM; Lenders JWM; Eisenhofer G
Eur J Endocrinol; 2017 Aug; 177(2):103-113. PubMed ID: 28476870
[TBL] [Abstract][Full Text] [Related]
10. Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status.
Eisenhofer G; Lenders JW; Siegert G; Bornstein SR; Friberg P; Milosevic D; Mannelli M; Linehan WM; Adams K; Timmers HJ; Pacak K
Eur J Cancer; 2012 Jul; 48(11):1739-49. PubMed ID: 22036874
[TBL] [Abstract][Full Text] [Related]
11. Common genetic mutations in the start codon of the SDH subunit D gene among Chinese families with familial head and neck paragangliomas.
Wang CP; Chen TC; Chang YL; Ko JY; Yang TL; Lo FY; Hu YL; Chen PL; Wu CC; Lou PJ
Oral Oncol; 2012 Feb; 48(2):125-9. PubMed ID: 21945342
[TBL] [Abstract][Full Text] [Related]
12. Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients.
Piccini V; Rapizzi E; Bacca A; Di Trapani G; Pulli R; Giachè V; Zampetti B; Lucci-Cordisco E; Canu L; Corsini E; Faggiano A; Deiana L; Carrara D; Tantardini V; Mariotti S; Ambrosio MR; Zatelli MC; Parenti G; Colao A; Pratesi C; Bernini G; Ercolino T; Mannelli M
Endocr Relat Cancer; 2012 Apr; 19(2):149-55. PubMed ID: 22241717
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of free metanephrines and 3-methoxytyramine indicate a higher number of biochemically active HNPGL than 24-h urinary excretion rates of catecholamines and metabolites.
van Duinen N; Corssmit EP; de Jong WH; Brookman D; Kema IP; Romijn JA
Eur J Endocrinol; 2013 Sep; 169(3):377-82. PubMed ID: 23832865
[TBL] [Abstract][Full Text] [Related]
14. Paraganglioma of the Head and Neck: A Review.
Sandow L; Thawani R; Kim MS; Heinrich MC
Endocr Pract; 2023 Feb; 29(2):141-147. PubMed ID: 36252779
[TBL] [Abstract][Full Text] [Related]
15. High incidence of occult familial
Guha A; Vicha A; Zelinka T; Kana M; Musil Z; Pacak K; Betka J; Chovanec M; Plzak J; Boucek J
Front Endocrinol (Lausanne); 2023; 14():1278175. PubMed ID: 38144572
[TBL] [Abstract][Full Text] [Related]
16. FDG PET-CT imaging in head and neck paragangliomas: A centre experience.
Boughdad S; O'Connor A; Cook GJ; Pike L; Connor S; Obholzer R; Warbey V
Clin Endocrinol (Oxf); 2021 Aug; 95(2):315-322. PubMed ID: 33598922
[TBL] [Abstract][Full Text] [Related]
17. Identification of somatic VHL gene mutations in sporadic head and neck paragangliomas in association with activation of the HIF-1α/miR-210 signaling pathway.
Merlo A; de Quirós SB; de Santa-María IS; Pitiot AS; Balbín M; Astudillo A; Scola B; Arístegui M; Quer M; Suarez C; Chiara MD
J Clin Endocrinol Metab; 2013 Oct; 98(10):E1661-6. PubMed ID: 23902947
[TBL] [Abstract][Full Text] [Related]
18. Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma.
Eisenhofer G; Deutschbein T; Constantinescu G; Langton K; Pamporaki C; Calsina B; Monteagudo M; Peitzsch M; Fliedner S; Timmers HJLM; Bechmann N; Fankhauser M; Nölting S; Beuschlein F; Stell A; Fassnacht M; Prejbisz A; Lenders JWM; Robledo M
Clin Chem Lab Med; 2020 Oct; 59(2):353-363. PubMed ID: 33001846
[TBL] [Abstract][Full Text] [Related]
19. Clinical management of paragangliomas.
Corssmit EP; Romijn JA
Eur J Endocrinol; 2014 Dec; 171(6):R231-43. PubMed ID: 25063320
[TBL] [Abstract][Full Text] [Related]
20. Urinary 5-HIAA excretion is not increased in patients with head and neck paragangliomas.
van Hulsteijn LT; van Duinen N; Romijn JA; Smit JW; Corssmit EP
Int J Biol Markers; 2012 Jul; 27(2):e160-3. PubMed ID: 22653742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]